General Administration of food and Drug Administration: forbidding the production of Chinese medicine granules approved by local food and Drug Administration

Yesterday, the general office of the State Food and Drug Administration issued a notice on the processing specifications of Chinese herbal pieces and the pilot research and management of Chinese herbal formula granules The notice pointed out that, first of all, when formulating or revising the processing specifications of Chinese Herbal Pieces in their respective jurisdictions, they should strictly follow the relevant provisions of the drug administration law of the people's Republic of China and its implementing regulations, and the scope of their collection is limited to the processing methods and Chinese herbal pieces with local processing characteristics and characteristics of Chinese medicine At the same time, the scientific research products that are still in the stage of scientific research and have not obtained the recognized data on safety and effectiveness, as well as the products such as tablets and granules that are routinely managed according to preparations, shall not be managed as pieces of traditional Chinese medicine, and the processing specifications of pieces of traditional Chinese medicine shall not be formulated for them In addition, traditional Chinese medicine formula granules are still in the pilot study of scientific research The State Food and Drug Administration will work with relevant departments to promote the pilot study of traditional Chinese medicine formula granules, find problems, summarize experience and timely issue relevant regulations Before that, the provincial food and drug administration shall not approve the production of traditional Chinese medicine formula granules in any name.